GL1X · GenesisL1 explorer

MolNFT v1 · #150048 · protein

Crystal structure of the ACVR1 (ALK2) kinase in complex with a quinazolinone based ALK2 inhibitor with a 5-methyl core.

6GI6 · Activin receptor type-1: “Crystal structure of the ACVR1 (ALK2) kinase in complex with a quinazolinone based ALK2 inhibitor with a…”. X-ray diffraction, 2 ligands (EZB, SO4), 3 pockets (best druggability 0.71). MolNFT v1 #150048 on…

PDB
6GI6
Type
protein
Length
298 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Activin receptor type-1
EC
2.7.11.30
UniProt
Q04771
Ligands
EZB, SO4
Pockets
3 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 38% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AActivin receptor type-1 (EC 2.7.11.30)protein29838% helix, 22% strandQ04771

Ligands and binding sites

  • EZB · 5-methyl-6-quinolin-5-yl-3~{H}-quinazolin-4-one · ligand · chains A
  • SO4 · Sulfate ion · ion · 4 copies · chains A
  • EDO · 1,2-ethanediol · additive · 10 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15430.710.8050EZB, SO4, EDO
21100.550.8319EDO
3660.350.7719EDO

Compared structures

  • 6GI6 · Crystal structure of the ACVR1 (ALK2) kinase in complex with a Quinazoli based ALK2… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q04771 · AlphaFold monomer V2.0 prediction for activin receptor type-1 (Q04771) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.